Startup Stage:Company - 2022, Luxembourg ⎥ TRL8 / CRL7
Value Proposition: A biotech platform to help healthcare industry detect respiratory hazards early by using a patented in vitro lung model with >95% specificity and no animal testing
Product: Bio + Digital, AI
Market: Health
IP: License ⎪ 2 Patents
Founders (ext.): CEO, Arno Gutleb│COO, Asier Sesma│CSO, Sabina Burla
Contact (int.): Ventures, Alex Godlewski
Revenue: First revenue - Pharma
Funding: Seed (Expon Capital, Angels, Fit 4 Start) │ ~€1M raised in total
